Cartesian Therapeutics(DE:1S70)
€5.25-0.40 (-7.08%)
DE:1S70
Cartesian Therapeutics earnings date
€5.25
At close:-0.40 (-7.08%)
Cartesian Therapeutics (1S70) Q2 2021 Earnings Report
1 Followers
DE:1S70 Q2 2021 EPS Results
- Actual EPS
- EUR 0.00
- Consensus EPS
- -EUR 0.10
- Beat/Miss
- Beat by +EUR 0.10
- One Year Ago EPS
- -EUR 0.22
DE:1S70 Q2 2021 Revenue Results
- Actual Revenue
- EUR 17.61M
- Expected Revenue
- EUR 6.38M
- Beat/Miss
- Beat by +EUR 11.22M
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 08/12/2021
- Time
- Before Open
- Conference Call
- Thursday, August 12, 2021
DE:1S70 Upcoming Earnings
Cartesian Therapeutics's next earnings date is estimated for March 17, 2027, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:1S70 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 17, 2027 | 2026 (Q4) | -0.81- | -3.1 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | -0.90-0.34 | -1.24 | 72.46% (+0.90) | |
| Aug 06, 2026 | 2026 (Q2) | -0.790.41 | 0.45 | -8.00% (-0.04) | |
| May 07, 2026 | 2026 (Q1) | -0.78-1.31 | -0.61 | -114.71% (-0.70) | |
| Mar 09, 2026 | 2025 (Q4) | -0.76-3.10 | -0.53 | -485.45% (-2.57) | |
| Nov 06, 2025 | 2025 (Q3) | -0.76-1.24 | -1.01 | -22.12% (-0.22) | |
| Aug 07, 2025 | 2025 (Q2) | -0.720.45 | 0.48 | -7.41% (-0.04) | |
| May 08, 2025 | 2025 (Q1) | -0.63-0.61 | -9.4 | 93.52% (+8.79) | |
| Mar 13, 2025 | 2024 (Q4) | -0.74-0.53 | -1.94 | 72.76% (+1.41) | |
| Nov 07, 2024 | 2024 (Q3) | -0.72-1.01 | -1.21 | 16.30% (+0.20) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

